Malignant transformation of mammalian cells with ras family oncogenes results in dramatic changes in cellular architecture and growth traits. The generation of flat revertants of v-K-ras-transformed renal cells by exposure to the histone deacetylase inhibitor sodium butyrate (NaB) was previously found to be dependent on transcriptional activation of the PAI-1 (SERPINE1) gene (encoding the type-1 inhibitor of urokinase and tissue-type plasminogen activators). NaB-initiated PAI-1 expression preceded induced cell spreading and entry into G 1 arrest. To assess the relevance of PAI-1 induction to growth arrest in this cell system more critically, two complementary approaches were used. The addition of a stable, long half-life, recombinant PAI-1 mutant to PAI-1-deficient v-K-ras-/c-Ha-ras-transformants or to PAI-1 functionally null, NaB-resistant, 4HH cells (engineered by antisense knockdown of PAI-1 mRNA transcripts) resulted in marked cytostasis in the absence of NaB. The transfection of ras-transformed cells with the Rc/CMVPAI expression construct, moreover, significantly elevated constitutive PAI-1 synthesis (10-to 20-fold) with a concomitant reduction in proliferative rate. These data suggest that high-level PAI-1 expression suppresses growth of chronic ras-oncogene transformed cells and is likely a major cytostatic effector of NaB exposure.
Introduction
Histone acetyltransferases (HATs) transfer acetyl groups from acetyl CoA to specific lysine residues in the amino terminal histone "tails" to form ε-N-acetyl lysine promoting an "open" or relaxed chromatin structure. Several transcriptional coactivators, including CBP/p300 and SRC, have intrinsic HAT activity [1, 2] . Histone deacetylases (HDACs), in contrast, catalyze the removal of acetyl groups on target lysines [3, 4] creating a condensed, transcriptionally repressed, chromatin organization [5] . Of the various HDAC inhibitors (HDACi), several exhibit more or less specificity for individual members of the four classes (I-VI) of human HDACs [6, 7] .
A major mode of action of HDACi (i.e., the transcription-dependent mechanism) [5] affects gene reprogramming as a consequence of HDACi type, concentration, and duration of exposure [8, 9] . Recent estimates place the number of HDACi-impacted genes at 2-10% of the total expressed repertoire, several of which negatively regulate cell cycle progression [10] [11] [12] [13] such as p21 WAF1/CIP1 and plasminogen activator inhibitor type-1 (PAI-1; SERPINE1) [14] [15] [16] [17] [18] [19] [20] [21] . PAI-1 is particularly relevant in this context as this SERPIN complexes with both urokinase (uPA) and tissue-type (tPA) plasminogen activators to limit pericellular plasmin generation effectively attenuating uPA-/plasmin-dependent growth factor activation and cellular proliferative responses [22, 23] . PAI-1, in fact, is both necessary and sufficient for p53-dependent growth arrest [23] [24] [25] [26] and required for TGF-β1-mediated antiproliferative effects in human keratinocytes and mouse embryo fibroblasts [27] . Activated ras or raf oncogenes trigger the initiation of a senescence-like growth arrest program, with induction of PAI-1, in several cell types [28] [29] [30] [31] . At least some cells transformed as a consequence of chronic oncogenic ras expression, and that escape ras-induced senescence can also undergo proliferative arrest upon exposure to certain HDACi (e.g., sodium butyrate; NaB) with concomitant high-level PAI-1 induction [16, 17, 32] . It is not known, however, if HDACi-associated growth inhibition of immortalized ras-transformants, like 2 International Journal of Cell Biology entrance of normal cells into replicative senescence [23] , also requires PAI-1-induction. This paper details the involvement of PAI-1 expression during HDACi-induced growth restriction in several wellcharacterized v-Ki-ras and Ha-ras val−12 -transformed epithelial cell lines [15, 16] . NaB was selected for this study as this HDACi is a potent stimulator of PAI-1 expression [14, 20] and cytostasis [16] in ras-transformed renal cells. NaBmediated growth inhibition was not evident in PAI-1 knockdown (i.e., anti-sense) cells, but the HDACi-dependent proliferative block could be rescued by vector-driven PAI-1 overexpression.
Materials and Methods

Culture Conditions and Engineered Cells.
The various ras-transformed renal epithelial cell lines used in this study [15, 16] grow in serum-free DMEM (at least over the short time frame used in this study; 3-5 days) facilitating assessments of the proliferation-modulating effects of NaB (1-10 mM) and exogenous PAI-1 (0.02-100 nM stable mutant 14-1B, t 1/2 = 145 hours; N150H, K154T, Q319L, M354I) [33] in both the presence and absence of FBS. The derivation of the PAI-1 functionally null knockdown (PAI-1 KD ) 4HH cell line by transfection of a 2.6 kb rat PAI-1 EcoR1/HindIII cDNA fragment (representing nucleotides −118 to +2572) cloned in anti-sense orientation (Rc/CMVIAP) has been described [34, 35] . v-rastransformed cells were also transfected with the Rc/CMVPAI sense vector to initiate high-level PAI-1 expression in the absence of NaB or with the empty Rc/CMV construct [32] . Coupled in vitro transcription/translation assay confirmed that a full-length immunoreactive PAI-1 protein was synthesized using the Rc/CMVPAI vector as a template [35] . In some cases, Rc/CMVPAI transfectants were selected with G418 [32] . Cloning strategy and cell line derivation are detailed in the text. c-Ha-ras oncogene-expressing human HaCaT II-4 keratinocytes were described previously [33, 36] as were the PAI-1-deficient and reconstituted renal cell lines [35] .
Northern
Blotting. Cytoplasmic RNA was separated by electrophoresis on denaturing 1% agarose/2.2 M formaldehyde gels, transferred to nitrocellulose and blots hybridized with a 32 P-labeled EcoRI-HindIII fragment of rat PAI-1 cDNA (specific activity 1-2 × 10 8 cpm/μg DNA) for 48 hr at 4
• C. The recombinant pBluescript (SK(-) phagemid pRPAISS1-3, containing a 3.0-kb EcoRI/SstII-flanked cDNA insert encoding PAI-1, was used for isolation of the pRPAImr1-4 probe used for hybridization. Briefly, pRPAISS1-3 was digested with EcoRI/Hind III at 37
• C for 1 hr and fragments separated in 1% agarose gels. After staining with ethidium bromide, bands representing the PAI-1 cDNA insert were excised and electroeluted. This insert fragment (pRPAImr1-4) was labeled with 32 P-dCTP by random priming. Following hybridization, membranes were washed sequentially for 20 minutes each in 2x SSC/0.1% SDS (twice) and then in 1x SSC/0.1% SDS, all at 55
• C.
Extraction of Metabolically Labeled Cells and Gel Electrophoresis.
Growth media (in 35-mm diameter cultures) were aspirated, cells washed twice with HBSS and 1 mL of labeling medium (FBS-and methionine-free RPMI 1640 medium containing 50 μCi 35 S-methionine (specific activity = 1100 Ci/mmol) added to each culture. At the end of a 6 hr labeling period, the substrate adherent-enriched (SAP) cellular fraction was collected, clarified at 13,000 ×g, and solubilized in lysis buffer (9.8 M urea, 2% Nonidet P-40, 2% ampholytes, and 100 mm dithiothreitol) [37] . 1-D gel separations were as detailed previously [38] . For 2-D gel electrophoresis, 50,000 cpm 35 S-methionine-labeled protein were loaded onto prerun 1.5 mm diameter tube gels (9.1 M urea, 2% Nonidet P-40, 6% pH 5-7 ampholytes, 1.2% pH 3-10 ampholytes, 4% acrylamide/bisacrylamide for isoelectric focusing (IEF) for 18 hr prior to separation on SDS-10% acrylamide slab gels [39] . Individual protein spots were mapped and quantitated with a Bio-Image Investigator 2-D Electrophoresis Analysis system interfaced to a SUN SPARC workstation [40] .
Results
PAI-1 Induction in v-ras-Transformed Renal Cells upon
Exposure to the HDACi NaB. Limited expression profiling previously indicated that PAI-1 was among the most abundant of the NaB-upregulated genes in ras-transformed renal epithelial cells [14, 15] consistent with microarray and bioinformatic analyses of genetic networks responsive to NaB in colonic epithelial cells [20] . 1-D electrophoresis (Figure 1(a) ), northern blotting ( Figure 1(b) ), and 2-D proteomic mapping (Figure 1(c) ), moreover, confirmed a significant and rather selective PAI-1 induction in NaB-stimulated v-ras-transformants (involving both the 50-kD and mature 52-kD glycosylated PAI-1 species), using 1-D/2-D mobility and immunochemical identification criteria established previously [16, 38, 41] , relative to nondetectable PAI-1 levels in control v-ras populations. PAI-1 upregulation correlated with a prominent NaB-associated G 1 arrest increased cell size ( Figure 2 ) and concentration-dependent proliferative inhibition resulting in a 63% (Figure 3(a) ) and 48% ( Figure 3(b) ) decrease in population density in serum-free and 10% serum-supplemented medium, respectively (summarized in Figure 4 ). Collectively, these findings ( Figures 1 and 4) are consistent with the conclusion that v-ras-transformants that escape ras oncogene-initiated cellular senescence [29, 42, 43] are essentially PAI-1 null.
Growth Arrest in ras-Transformants Is Restored by Exogenous Exposure to a Long Half-Life PAI-1 Mutant or by VectorDriven Reconstitution of PAI-1 Expression.
Since targeted suppression of PAI-1 leads to bypass of both replicative senescence and TGF-β-induced growth arrest [23, 27] , it was important to determine if exogenously-delivered PAI-1 could similarly regulate the proliferative response of PAI-1-deficient ras transformants in the absence of NaB cells in a concentration-dependent manner with an 80% reduction in final population density after a 5-day exposure to 100 nM PAI-1 ( Figure 5(a)) . Indeed, the level of growth inhibition in cultures exposed to 20 nM PAI-1 (45% reduction in population density relative to the corresponding control) ( Figure 5(a) ) approximated the 47.5% decrease induced by 10 mM NaB even in the presence of serum (Figure 4(b) ). Ha-ras-transformed HaCaT cells, which express low levels of PAI-1 in response to EGF [33] , were also growth inhibited by exposure to PAI-1 14-1B in the presence of FBS or EGF (Figures 5(b) and 5(c) ) largely due to G 1 arrest (Figure 5(c) ). To assess this effect more critically in a genetic context, antisense knockdown (PAI-1 KD ; 4HH) cells (Figure 6(a) ), which are resistant to NaB-dependent proliferative inhibition, were incubated in PAI-1-supplemented medium with or without, addition of NaB. Recombinant PAI-1, at a final concentration of 20 nM, effectively suppressed PAI-1 KD cell proliferation; the combination of PAI-1 + NaB did not significantly impact the extent of cytostasis compared to PAI-1 alone (Figure 6 
Discussion
Data mining of microarray and serial analysis of gene expression profiles consistently identified increased PAI-1 levels as characteristic of specific growth arrest states (e.g., [23, 27, 35, 36, 39, [42] [43] [44] [45] [46] ). Similar to other HDACi-regulated genes, several of which negatively regulate cell cycle progression [10] [11] [12] [13] , PAI-1 is a particularly relevant candidate as this SERPIN attenuates uPA-/plasmin-dependent growth factor activation and cellular proliferative responses [22, 23] , mediates p53-dependent cytostasis [23] [24] [25] [26] , and is required for TGF-β1-mediated antiproliferative responses [27] . In cells expressing activated ras or raf oncogenes, moreover, induced PAI-1 initiates the engagement of a senescencelike phenotype [28] [29] [30] [31] while, for those cells that escape ras-induced senescence, the growth arrest program can be "rescued" upon exposure to certain HDACi (e.g., NaB) with concomitant high-level PAI-1 induction [16, 17, 32] . While molecular events underlying NaB-stimulated PAI-1 expression is unclear, NaB enhances Smad3 phosphorylation and potentiates TGF-β-induced PAI-1 expression [47] , concomitant with NaB-induced G 1 arrest [48] . Indeed, overexpression of SMAD3 in v-Ha-ras-transformed keratinocytes induced a cytostatic response, stimulated PAI-1 promoter Figure 3 : NaB suppressed cell growth in serum-free or supplemented culture conditions. Proliferative restriction was maximal at 10 mM resulting in final population densities of just 47% (a) and 52% (b) compared to respective controls. Data plotted is the mean ± standard deviation for triplicate assessments of final cell densities (i.e., % confluency) for each NaB concentration under the two growth conditions. Figure 2 ). Cells remained growth arrested even after protracted treatment (e.g., 46 days) although such long-term cultures had an increased binucleate frequency. PAI-1 mRNA/protein expression in control populations was low to undetectable in contrast to the levels of PAI-1 transcripts and protein evident in response to NaB. Plots illustrate the mean ± standard deviation for triplicate assessments for each of the parameters evaluated. Figure 6: PAI-1 antisense and sense expression vectors were used to generate the PAI-1 knockdown (4HH; PAI-1 KD ) and overexpressing (Rc/CMVPAI) cell lines, respectively, (a). PAI-1-deficient 4HH cells were resistant to NaB-mediated cytostasis but remained sensitive to PAI-1-induced growth arrest. The combination of NaB+PAI-1 reduced final population densities similar to that of PAI-1 alone cultures (b). Vector-driven PAI-1 overexpression in v-ras transformants also inhibited cell growth consistent with results of the PAI-1 add-back experiments (e.g., Figure 5 ). Data plotted represents the mean ± standard deviation for triplicate assessments of final cell densities (i.e., % confluency).
(3TP-Lux reporter)-dependent transcription, and increased the incidence of senescent epithelial cells [49] . The present findings are consistent with these and previous data that TGF-β-initiated growth inhibition as well as senescence arrest is PAI-1-dependent [23, 27] and establish, moreover, PAI-1 as a mediator of NaB-initiated cytostasis. Whether this response can be adapted for directed "senescence therapy" of human cancers, remains to be assessed.
NaB upregulates the cell cycle inhibitors p21 WAF1/CIP1 and p16 INK4A in human fibroblasts although targeted disruption of p21 only weakly impacted HDACi-induced senescencelike growth arrest. p53 −/− mouse embryo fibroblasts (MEFs), moreover, are resistant to NaB-initiated cytostasis indicating that this tumor suppressor is a major senescence determinant in MEFs [50] , and NaB-mediated apoptosis in human melanoma cells is p53-dependent [51] . Indeed, nutlin-3, an MDM2 inhibitor which restores p53 function in tumor cells that retain a wild-type p53, cooperate with several HDACis (including NaB) to induce cell death in p53 wild-type tumor cell lines but not in p53-null PC-3 prostatic carcinoma likely by HDACi-induced p53 hyperacetylation and/or MDM2/MDM4 downregulation [52] . This may be dependent, in part, on the extent of increased p53 expression in response to NaB [53] . Similarly, NaB-stimulated p53 transcriptional activity initiated irreversible G 1 /S cell cycle arrest in c-Ha-ras-transformed rat embryo fibroblasts that were p53 wild-type but not in cells with an inactivated p53 [54] . While the actual contribution of p21 versus INK4A/ARF-encoded genes (e.g., p19) in NaB-induced growth arrest is uncertain [55, 56] , the role of p53 (at least in MEFs) may be more relevant since p53 is required for PAI-1 expression and growth arrest (see [27, 57] ; and Overstreet et al., in preparation). p53 status, therefore, may be a major aspect of HDACi-induced cell cycle arrest through its transcriptional control of PAI-1 and, thereby, PAI-1-dependent cytostasis.
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